AAAAAA

   
Results: 1-15 |
Results: 15
A DOSE-FINDING STUDY FOR THE COMBINATION OF EPIDOXORUBICIN AND VINORELBINE, DELIVERED EVERY 2 WEEKS WITH G-CSF SUPPORT, IN ADVANCED BREAST-CANCER
Authors: PRONZATO P TOGNONI A PENSA F VAIRA F VIGANI A
Citation: P. Pronzato et al., A DOSE-FINDING STUDY FOR THE COMBINATION OF EPIDOXORUBICIN AND VINORELBINE, DELIVERED EVERY 2 WEEKS WITH G-CSF SUPPORT, IN ADVANCED BREAST-CANCER, Journal of chemotherapy, 10(4), 1998, pp. 326-330
A PHASE-II TRIAL OF CARBOPLATIN, METHOTREXATE AND FLUOROURACIL IN FLUOROURACIL-PRETREATED COLORECTAL-CANCER
Authors: PRONZATO P BOTTO F GHIO E PENSA F TOGNONI A VAIRA F VIGANI A NERI E
Citation: P. Pronzato et al., A PHASE-II TRIAL OF CARBOPLATIN, METHOTREXATE AND FLUOROURACIL IN FLUOROURACIL-PRETREATED COLORECTAL-CANCER, Journal of chemotherapy, 10(3), 1998, pp. 254-257
CORRELATION BETWEEN PLASMA TRANSFORMING GROWTH-FACTOR-BETA-1 AND 2ND PRIMARY BREAST-CANCER IN A CHEMOPREVENTION TRIAL
Authors: DECENSI A TORRISI R FONTANA V BARRECA A PONZANI P PENSA F PARODI S COSTA A
Citation: A. Decensi et al., CORRELATION BETWEEN PLASMA TRANSFORMING GROWTH-FACTOR-BETA-1 AND 2ND PRIMARY BREAST-CANCER IN A CHEMOPREVENTION TRIAL, European journal of cancer, 34(7), 1998, pp. 999-1003
HIGH-DOSE-INTENSITY COMBINATION CHEMOTHERAPY FOR ADVANCED SARCOMAS - A PILOT-STUDY
Authors: PRONZATO P LOSARDO P PENSA F TOGNONI A
Citation: P. Pronzato et al., HIGH-DOSE-INTENSITY COMBINATION CHEMOTHERAPY FOR ADVANCED SARCOMAS - A PILOT-STUDY, Cancer chemotherapy and pharmacology, 41(6), 1998, pp. 513-516
EFFECT OF FENRETINIDE ON PLASMA IGF-I AND IGFBP-3 IN EARLY BREAST-CANCER PATIENTS
Authors: TORRISI R PARODI S FONTANA V PENSA F CASELLA C BARRECA A DEPALO G COSTA A DECENSI A
Citation: R. Torrisi et al., EFFECT OF FENRETINIDE ON PLASMA IGF-I AND IGFBP-3 IN EARLY BREAST-CANCER PATIENTS, International journal of cancer, 76(6), 1998, pp. 787-790
HIGH-DOSE INTENSITY CYCLOPHOSPHAMIDE, EPIDOXORUBICIN, VINCRISTINE ANDPREDNISONE BY SHORTENED INTERVALS AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN NON-HODGKINS-LYMPHOMA - A PHASE-II STUDY
Authors: PRONZATO P LIONETTO R BOTTO F PENSA F TOGNONI A
Citation: P. Pronzato et al., HIGH-DOSE INTENSITY CYCLOPHOSPHAMIDE, EPIDOXORUBICIN, VINCRISTINE ANDPREDNISONE BY SHORTENED INTERVALS AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN NON-HODGKINS-LYMPHOMA - A PHASE-II STUDY, British Journal of Cancer, 78(6), 1998, pp. 777-780
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORS IN LOW-DOSES AND INTENSITY OF CHEMOTHERAPY
Authors: PRONZATO P PENSA F VAIRA F VIGANI A
Citation: P. Pronzato et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORS IN LOW-DOSES AND INTENSITY OF CHEMOTHERAPY, Tumori, 83(5), 1997, pp. 8-12
2ND LINE CHEMOTHERAPY WITH IFOSFAMIDE AS OUTPATIENT TREATMENT FOR ADVANCED BLADDER-CANCER
Authors: PRONZATO P VIGANI A PENSA F VANOLI M TANI F VAIRA F
Citation: P. Pronzato et al., 2ND LINE CHEMOTHERAPY WITH IFOSFAMIDE AS OUTPATIENT TREATMENT FOR ADVANCED BLADDER-CANCER, American journal of clinical oncology, 20(5), 1997, pp. 519-521
A NEW SCHEDULE FOR ETOPOSIDE, EPIDOXORUBICIN AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR FOR ADVANCED GASTRIC-CANCER - A FEASIBILITY STUDY
Authors: PRONZATO P VIGANI A PENSA F BOTTO F GHIO E NERI E TOGNONI A VAIRA F
Citation: P. Pronzato et al., A NEW SCHEDULE FOR ETOPOSIDE, EPIDOXORUBICIN AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR FOR ADVANCED GASTRIC-CANCER - A FEASIBILITY STUDY, Anticancer research, 17(5B), 1997, pp. 3873-3876
THE METABOLITE N-4-METHOXYPHENYLRETINAMIDE IS A MAJOR DETERMINANT OF FENRETINIDE INDUCED DECLINE OF PLASMA INSULIN-LIKE GROWTH-FACTOR-I
Authors: TORRISI R PENSA F FONTANA V COSTA A DECENSI A
Citation: R. Torrisi et al., THE METABOLITE N-4-METHOXYPHENYLRETINAMIDE IS A MAJOR DETERMINANT OF FENRETINIDE INDUCED DECLINE OF PLASMA INSULIN-LIKE GROWTH-FACTOR-I, European journal of cancer, 31A(3), 1995, pp. 420-421
INSULIN-LIKE-GROWTH-FACTOR-I (IGF-I) AND IGF-BINDING PROTEINS BLOOD-SERUM LEVELS IN WOMEN WITH EARLY-STAGE AND LATE-STAGE BREAST-CANCER - MUTUAL RELATIONSHIP AND POSSIBLE CORRELATIONS WITH PATIENTS HORMONAL STATUS
Authors: FAVONI RE DECUPIS A PERROTTA A SFORZINI S AMOROSO D PENSA F MIGLIETTA L
Citation: Re. Favoni et al., INSULIN-LIKE-GROWTH-FACTOR-I (IGF-I) AND IGF-BINDING PROTEINS BLOOD-SERUM LEVELS IN WOMEN WITH EARLY-STAGE AND LATE-STAGE BREAST-CANCER - MUTUAL RELATIONSHIP AND POSSIBLE CORRELATIONS WITH PATIENTS HORMONAL STATUS, Journal of cancer research and clinical oncology, 121(11), 1995, pp. 674-682
EPIDERMAL GROWTH-FACTOR CONTENT OF BREAST CYST FLUIDS FROM WOMEN WITHBREAST-CANCER OR PROLIFERATIVE DISEASE OF THE BREAST
Authors: TORRISI R ZANARDI S PENSA F VALENTI G DEFRANCHIS V NICOLO G BARRECA A MINUTO F BOCCARDO F
Citation: R. Torrisi et al., EPIDERMAL GROWTH-FACTOR CONTENT OF BREAST CYST FLUIDS FROM WOMEN WITHBREAST-CANCER OR PROLIFERATIVE DISEASE OF THE BREAST, Breast cancer research and treatment, 33(3), 1995, pp. 219-224
EFFECT OF THE NONSTEROIDAL ANTIANDROGEN NILUTAMIDE ON ADRENAL ANDROGEN SECRETION
Authors: DECENSI A TORRISI R MARRONI P PENSA F PADOVANI P BOCCARDO F
Citation: A. Decensi et al., EFFECT OF THE NONSTEROIDAL ANTIANDROGEN NILUTAMIDE ON ADRENAL ANDROGEN SECRETION, The Prostate, 24(1), 1994, pp. 17-23
PRESENCE OF IMMUNOASSAYABLE TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BETA-1) IN BREAST CYST FLUID (BCF) - RELATIONSHIP WITH THE INTRACYSTIC ELECTROLYTE AND EPIDERMAL-GROWTH-FACTOR (EGF) CONTENT
Authors: ZANARDI S PENSA F TORRISI R DEFRANCHIS V BARRECA A MINUTO F BOCCARDO F
Citation: S. Zanardi et al., PRESENCE OF IMMUNOASSAYABLE TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BETA-1) IN BREAST CYST FLUID (BCF) - RELATIONSHIP WITH THE INTRACYSTIC ELECTROLYTE AND EPIDERMAL-GROWTH-FACTOR (EGF) CONTENT, International journal of cancer, 59(6), 1994, pp. 725-727
THE SYNTHETIC RETINOID FENRETINIDE LOWERS PLASMA INSULIN-LIKE GROWTH FACTOR-I LEVELS IN BREAST-CANCER PATIENTS
Authors: TORRISI R PENSA F ORENGO MA CATSAFADOS E PONZANI P BOCCARDO F COSTA A DECENSI A
Citation: R. Torrisi et al., THE SYNTHETIC RETINOID FENRETINIDE LOWERS PLASMA INSULIN-LIKE GROWTH FACTOR-I LEVELS IN BREAST-CANCER PATIENTS, Cancer research, 53(20), 1993, pp. 4769-4771
Risultati: 1-15 |